KPTI - Karyopharm Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KPTI is currently covered by 3 analysts with an average price target of $6.67. This is a potential upside of $5.6 (523.36%) from yesterday's end of day stock price of $1.07.

Karyopharm Therapeutics's activity chart (see below) currently has 17 price targets and 16 ratings on display. The stock rating distribution of KPTI is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 28.55% with an average time for these price targets to be met of 84.73 days.

Highest price target for KPTI is $18, Lowest price target is $4, average price target is $6.67.

Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 09-May-2024. First documented stock forecast 02-Jun-2015.

Currently out of the existing stock ratings of KPTI, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

18

$6.41 (55.31%)

17

9 days ago

0/5 (0%)

$6.41 (55.31%)

Buy

8

$-3.59 (-30.97%)

9 days ago

0/1 (0%)

$-3.59 (-30.97%)

Hold

4

$2.69 (205.34%)

10

9 months 11 days ago

6/11 (54.55%)

$2.39 (148.45%)

305

Hold

5

$3.69 (281.68%)

6

1 years 4 months 8 days ago

3/7 (42.86%)

$2.13 (74.22%)

225

Buy

14

$12.69 (968.70%)

22

1 years 9 months 13 days ago

0/5 (0%)

$9.32 (199.15%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KPTI (Karyopharm Therapeutics) average time for price targets to be met?

On average it took 84.73 days on average for the stock forecasts to be realized with a an average price target met ratio 28.55

Which analyst has the current highest performing score on KPTI (Karyopharm Therapeutics) with a proven track record?

MICHAEL ULZ

Which analyst has the most public recommendations on KPTI (Karyopharm Therapeutics)?

Michael Ulz works at MORGAN STANLEY and has 2 price targets and 2 ratings on KPTI

Which analyst is the currently most bullish on KPTI (Karyopharm Therapeutics)?

Maury Raycroft with highest potential upside - $33.69

Which analyst is the currently most reserved on KPTI (Karyopharm Therapeutics)?

Edward White with lowest potential downside - -$3.59

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?